Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0HB6O
|
||||
| Former ID |
DNC007948
|
||||
| Drug Name |
H-Cdp-Gly-Gly-Phe-Leu-OH
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [528724] | ||
| Formula |
C31H42N6O7
|
||||
| Canonical SMILES |
CC1=CC(=CC(=C1CC(C(=O)NCC(=O)NCC(=O)NC(CC2=CC=CC=C2)C(=<br />O)NC(CC(C)C)C(=O)O)N)C)C(=O)N
|
||||
| InChI |
1S/C31H42N6O7/c1-17(2)10-25(31(43)44)37-30(42)24(13-20-8-6-5-7-9-20)36-27(39)16-34-26(38)15-35-29(41)23(32)14-22-18(3)11-21(28(33)40)12-19(22)4/h5-9,11-12,17,23-25H,10,13-16,32H2,1-4H3,(H2,33,40)(H,34,38)(H,35,41)(H,36,39)(H,37,42)(H,43,44)/t23-,24-,25-/m0/s1
|
||||
| InChIKey |
AYRRYHMNASIQTF-SDHOMARFSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Mu-type opioid receptor | Target Info | Inhibitor | [528724] | |
| Delta-type opioid receptor | Target Info | Inhibitor | [528724] | ||
| Kappa-type opioid receptor | Target Info | Inhibitor | [528724] | ||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
| Enkephalin releaseP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Enkephalin release | |||||
| Opioid proenkephalin pathway | |||||
| Opioid proopiomelanocortin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Opioid prodynorphin pathway | |||||
| Pathway Interaction Database | IL4-mediated signaling events | ||||
| References | |||||